zhu jiyun

Dr. zhu jiyun


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2024 in International Journal of Surgery
Verified
Journal Article
Open access
YSYu-Qin Sun
Yu-Qin Sun
QZQing Zhong
Qing Zhong
CLChen-Bin Lv
Chen-Bin Lv
ZJzhu jiyun
zhu jiyun
GLGuang-Tan Lin
Guang-Tan Lin
CHChangming Huang
Changming Huang
Background: The safety and efficacy of neoadjuvant immunochemotherapy (nICT) for locally advanced gastric cancer (LAGC) remain controversial. Methods: Patients with LAGC who received either nICT or neoadjuvant chemotherapy (nCT) at 3 tertiary referral teaching hospitals in China between January 2016 and October 2022 were analyzed. After propensity-score matching (PSM), comparing the radiological response, pathological response rate, perioperative outcomes, and early recurrence between the two groups. Results: After PSM, 585 patients were included, with 195 and 390 patients comprising the nICT and nCT groups, respectively. The nICT group exhibited a higher objective response rate (79.5% vs. 59.0%; P<0.001), pathological complete response rate (14.36% vs. 6.41%; P=0.002) and major pathological response rate (39.49% vs. 26.15%; P=0.001) compared with the nCT group. The incidence of surgical complications (17.44% vs. 16.15%, P=0.694) and the proportion of perioperative textbook outcomes (80.0% vs. 81.0%; P=0.767) were similar in both groups. The nICT group had a significantly lower proportion of early recurrence than the nCT group (29.7% vs. 40.8%; P=0.047). Furthermore, the multivariable logistic analysis revealed that immunotherapy was an independent protective factor against early recurrence [odds ratio 0.62 (95% CI 0.41–0.92); P=0.018]. No significant difference was found in neoadjuvant therapy drug toxicity between the two groups (51.79% vs. 45.38%; P=0.143). Conclusions: Compared with nCT, nICT is safe and effective, which significantly enhanced objective and pathological response rates and reduced the risk for early recurrence among patients with LAGC. Trial registration: Clinical Trials.gov.

1 May 2021 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
ZJzhu jiyun
zhu jiyun
JQJiangfeng Qiu
Jiangfeng Qiu
KCKaibo Chen
Kaibo Chen
WWWenbo Wang
Wenbo Wang
SZSiming Zheng
Siming Zheng
Hepatopulmonary syndrome (HPS) is characterized by pulmonary vasodilation and arterial blood oxygen desaturation in patients with chronic liver disease. Generally, common bile duct ligation (CBDL) rats are a suitable experimental model for studying hepatopulmonary syndrome. Our previous study demonstrated that endotoxin surges markedly, followed by bacterial translocation and the loss of liver immune function in all the stages of CBDL, thereby contributing to the pathogenesis of HPS. However, the mechanisms behind the increase of the endotoxin and how to alleviate it have not yet been elucidated. Pulmonary injury induced by increased bilirubin, endotoxin, and inflammatory mediators occurs in the early and later stages of CBDL. This study assessed the effects of Tea polyphenols (TP) and Levofloxacin on endotoxin reduction and suppression of lung injury in HPS rats in the long and short term, respectively. Morphological change of pulmonary injury, HPS relative index, endotoxin concentration, and the activation extent of Malondialdehyde (MDA) and Myeloperoxidase (MPO) were evaluated in CBDL rats with or without TP and Levofloxacin for three weeks or six weeks. The inflammation factors of serum, lung tissue, and BALF were then compared at the same condition for the two time periods. This was followed by adoption of the network pharmacology approach, which was mainly composed of active component gathering, target prediction, HPS gene collection, network analysis, and gene enrichment analysis. Finally, the mRNA and protein levels of the inflammatory factors were studied and relative signaling expression was assessed using RT-PCR and Western blot analysis. The obtained results indicated that the pulmonary injury manifestation was perceived and endotoxin, MDA, and MPO activation were markedly increased in the early and later stages of CBDL. TP and Levofloxacin treatment alleviated endotoxin infection and inflammation factor expression three weeks and six weeks after CBDL. In addition, Levofloxacin displayed a short time anti-bacterial effect, while TP exerted a long period function. TP and Levofloxacin also reduced TNF-α, TGF-β, IL-1β, PDGF-BB, NO, ICAM-1, and ET-1 expression on the mRNA or protein expression. With regard to the pharmacological mechanism, the network analysis indicated that 12 targets might be the therapeutic targets of TP and Levofloxacin on HPS, namely ET-1, NOs3, VEGFa, CCl2, TNF, Ptgs2, Hmox1, Alb, Ace, Cav1, and Mmp9. The gene enrichment analysis implied that TP and Levofloxacin probably benefited patients with HPS by modulating pathways associated with the AGE-RAGE signaling pathway, the TNF signaling pathway, the HIF-1 signaling pathway, the VEGF signaling pathway, and the IL-17 signaling pathway, Rheumatoid arthritis, Fluid shear stress, and atherosclerosis. Finally, the TNF-α level was mainly diminished on the protein level following CBDL. TP and Levofloxacin could alleviate pulmonary injury for short and long period, respectively, while at the same time preventing endotoxin and the development of HPS in CBDL rats. These effects are possibly associated with the regulation of the Endotoxin -TNF-α pathways.

25 July 2025 in Medicine
Verified
Journal Article
Open access
MZMengna Mm Zhang
Mengna Mm Zhang
BZBin Mm Zhang
Bin Mm Zhang
YZYing’an Mm Zhao
Ying’an Mm Zhao
AWAnle Wu
Anle Wu
ZJzhu jiyun
zhu jiyun
SZSiming Zheng
Siming Zheng
Objective: To summarize the clinical experience of a case report of pancreaticoduodenectomy (PD) with en bloc celiac axis (CA) resection for locally advanced pancreatic cancer. Methods: We retrospectively analyzed the clinical data of a patient with locally advanced pancreatic cancer who underwent PD with en bloc CA resection after neoadjuvant chemotherapy and embolization of the proper hepatic artery at the Department of Hepatopancreatobiliary Surgery of the First Affiliated Hospital of Ningbo University in May 2023. This study was approved by the ethics committee of the Ningbo First Hospital. Results: This case was operated on smoothly with an operative time of 535 minutes and intraoperative bleeding of approximately 800 mL. Only short-term elevation of hepatic aminotransferase appeared in the postoperative period, which was improved by hepatoprotective and symptomatic treatments. The patient was discharged from the hospital 20 days postoperatively, and no tumor recurrence occurred in the follow-up period. Conclusion: In patients with locally advanced pancreatic cancer with simultaneous invasion of the celiac trunk, common hepatic artery, and hepatic innominate artery, total PD with en bloc CA resection is safe and feasible in cases where neoadjuvant chemotherapy is effective and after establishing hepatic collateral circulation by preoperative embolization of the hepatic innominate artery. Meanwhile, more cases from more centers are needed to validate this conclusion.